News + Resources
Keep up with the latest
Featured
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Epigenetic editors are a gentler form of gene editing
February 24, 2025
The Economist
Epigenetic editors are a gentler form of gene editing
February 24, 2025
All Stories
News
DNA: Cutting the Future of Genome Editing
May 2, 2024
The Biomedical Scientist
Read Now
Press Release
DNA: Cutting the Future of Genome Editing
May 2, 2024
The Biomedical Scientist
Read Now
Press Release
Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
April 22, 2024
Read Now
Press Release
Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
April 22, 2024
Read Now
News
CRISPR technologies fuelling haematological innovations
April 12, 2024
European Pharmaceutical Review
Read Now
Press Release
CRISPR technologies fuelling haematological innovations
April 12, 2024
European Pharmaceutical Review
Read Now
News
CRISPR drug licensing deals secure $21bn in top three therapy areas over five years
March 28, 2024
Pharmaceutical Technology
Read Now
Press Release
CRISPR drug licensing deals secure $21bn in top three therapy areas over five years
March 28, 2024
Pharmaceutical Technology
Read Now